type here...

CATEGORIES

Press Release

LATEST

1234...12Page 3 of 12

TRENDING

EDITORS CHOICE

Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells

Medika Life -
An experimental compound prevents the virus that causes COVID-19 from entering human airway cells, a new study finds.

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

Medika Life -
Renowned Endocrinologist Leon Igel MD, Recognized for Pioneering Work in Diabetes and Obesity Management

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

NLR. Millions at Risk from Leprosy. Study Reveals Figures

Medika Life -
To interrupt leprosy transmission and reduce annual new cases significantly, preventive treatment needs to be implemented in all leprosy-endemic countries

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories